Joseph Shiloach Selected Research

Joseph Shiloach Research Topics

Disease

8	Infections 11/2020 - 01/2003
7	Anthrax 11/2020 - 07/2002
7	Neoplasms (Cancer) 04/2018 - 08/2012
2	Malaria 12/2023 - 07/2006
2	Inflammation (Inflammations) 11/2020 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 01/2014
2	Whooping Cough (Pertussis) 03/2014 - 04/2007
2	Bacillary Dysentery (Shigellosis) 03/2010 - 08/2003
1	Starvation 01/2022
1	Chronic Granulomatous Disease 03/2021
1	Tauopathies 01/2018
1	Sepsis (Septicemia) 01/2017
1	Hyperglycemia 01/2016
1	Vascular Calcification 12/2015
1	Sclerosis 12/2015
1	Arterial calcification of infancy 12/2015
1	Edema (Dropsy) 09/2013
1	Disseminated Intravascular Coagulation 09/2013
1	Poisoning 03/2013
1	Neoplasm Metastasis (Metastasis) 02/2013
1	Colorectal Neoplasms (Colorectal Cancer) 02/2013
1	Nervous System Diseases (Neurological Disorders) 10/2012
1	Obesity 10/2012
1	Duodenal Ulcer (Curling's Ulcer) 10/2011
1	Pathologic Neovascularization 01/2011
1	Ulcerative Colitis 01/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2011
1	Teratoma (Teratoid Tumor) 12/2010
1	Human Influenza (Influenza) 10/2009
1	Bites and Stings (Sting) 01/2007
1	Insulin Resistance 08/2006

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 10/2018 - 07/2002
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2003
4	AntibodiesIBA 03/2014 - 01/2004
3	AntigensIBA 10/2018 - 01/2004
2	Peptidoglycan (Murein)IBA 11/2020 - 09/2013
2	Conjugate VaccinesIBA 03/2014 - 08/2003
2	MicroRNAs (MicroRNA)IBA 02/2013 - 08/2012
2	EndostatinsIBA 10/2011 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 01/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2006 - 01/2004
2	Recombinant ProteinsIBA 06/2005 - 01/2003
2	Isopropyl Thiogalactoside (IPTG)IBA 03/2005 - 01/2003
2	Immunoglobulin G (IgG)IBA 08/2003 - 07/2003
1	Malaria VaccinesIBA 12/2023
1	CarbonIBA 01/2022
1	GlycolipidsIBA 03/2021
1	Lipid AIBA 03/2021
1	PENTAIBA 03/2021
1	AcidsIBA 03/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2018
1	Proline (L-Proline)FDA Link 01/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2017
1	EndotoxinsIBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	CRM 107 (CRM107)IBA 01/2017
1	alpha-MSHIBA 01/2017
1	Type 1 Melanocortin ReceptorIBA 01/2017
1	polyolIBA 01/2016
1	disodium (R,R)- 5- (2- ((2- (3- chlorophenyl)- 2- hydroxyethyl)- amino)propyl)- 1,3- benzodioxole- 2,3- dicarboxylateIBA 01/2016
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2016
1	diphosphoric acid (pyrophosphoric acid)IBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	TrisaccharidesIBA 03/2014
1	OligosaccharidesIBA 03/2014
1	Nonesterified Fatty Acids (NEFA)IBA 01/2014
1	Branched-Chain Amino AcidsIBA 01/2014
1	Dacarbazine (DIC)FDA LinkGeneric 09/2013
1	Oxygen (Dioxygen)IBA 03/2013
1	Antisense OligonucleotidesIBA 02/2013
1	LigandsIBA 10/2012
1	Peptides (Polypeptides)IBA 10/2012
1	AngiostatinsIBA 10/2011
1	Matrix Metalloproteinases (MMPs)IBA 10/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2011
1	stage-specific embryonic antigen-4IBA 12/2010
1	Alkaline PhosphataseIBA 12/2010
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2010
1	avian influenza A virus hemagglutininIBA 10/2009
1	aluminum sulfate (alum)IBA 10/2009
1	O Antigens (O Antigen)IBA 05/2009
1	pertussis toxoidIBA 04/2007
1	ToxoidsIBA 04/2007
1	AdiponectinIBA 08/2006
1	Lysine (L-Lysine)FDA Link 08/2006
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 08/2006
1	Arginine (L-Arginine)FDA Link 08/2006
1	Glucose (Dextrose)FDA LinkGeneric 08/2006
1	Insulin (Novolin)FDA Link 08/2006
1	DNA (Deoxyribonucleic Acid)IBA 07/2006
1	Codon (Codons)IBA 07/2006

Therapy/Procedure

4	Therapeutics 04/2018 - 07/2006
1	Ligation 01/2017
1	Punctures 01/2017